1. Home
  2. MTB vs ALC Comparison

MTB vs ALC Comparison

Compare MTB & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo M&T Bank Corporation

MTB

M&T Bank Corporation

SELL

Current Price

$219.01

Market Cap

31.3B

Sector

Finance

ML Signal

SELL

Logo Alcon Inc.

ALC

Alcon Inc.

SELL

Current Price

$73.74

Market Cap

32.6B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MTB
ALC
Founded
1856
1945
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Ophthalmic Goods
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.3B
32.6B
IPO Year
2011
2002

Fundamental Metrics

Financial Performance
Metric
MTB
ALC
Price
$219.01
$73.74
Analyst Decision
Hold
Buy
Analyst Count
22
27
Target Price
★ $245.93
$81.46
AVG Volume (30 Days)
691.8K
★ 2.1M
Earning Date
10-16-2026
11-10-2026
Dividend Yield
★ 2.71%
0.31%
EPS Growth
★ 16.12
N/A
EPS
★ 14.48
N/A
Revenue
★ $9,643,000,000.00
N/A
Revenue This Year
$3.85
$6.32
Revenue Next Year
$3.58
$6.14
P/E Ratio
★ $15.22
$38.31
Revenue Growth
★ 17.91
N/A
52 Week Low
$179.75
$61.84
52 Week High
$255.95
$87.64

Technical Indicators

Market Signals
Indicator
MTB
ALC
Relative Strength Index (RSI) 46.28 58.94
Support Level $211.94 $73.12
Resistance Level $222.19 $76.80
Average True Range (ATR) 4.31 1.67
MACD 0.03 -0.11
Stochastic Oscillator 15.92 56.48

Price Performance

Historical Comparison
MTB
ALC

About MTB M&T Bank Corporation

M&T Bank is a US regional bank with around $220 billion in assets as of the end of the second quarter of 2026. Headquartered in Buffalo, New York, the bank's footprint is mostly concentrated in New England and the US Mid-Atlantic. M&T Bank boasts a community banking approach, and boasts over 900 branches in 13 states and Washington, D.C. Apart from retail and commercial banking, M&T Bank also has wealth management operations through Wilmington Trust and a partnership with LPL Financial, and a corporate trust business.

About ALC Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Share on Social Networks: